KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Staar Surgical (STAA) Revenue (2016 - 2026)

Staar Surgical (STAA) has disclosed Revenue for 17 consecutive years, with $57.8 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Revenue rose 18.08% year-over-year to $57.8 million, compared with a TTM value of $239.4 million through Jan 2026, down 23.72%, and an annual FY2026 reading of $239.4 million, down 23.72% over the prior year.
  • Revenue was $57.8 million for Q1 2026 at Staar Surgical, down from $94.7 million in the prior quarter.
  • Across five years, Revenue topped out at $99.0 million in Q2 2024 and bottomed at $19.1 million in Q4 2022.
  • Average Revenue over 5 years is $69.7 million, with a median of $76.2 million recorded in 2022.
  • The sharpest move saw Revenue skyrocketed 3579.19% in 2022, then plummeted 55.23% in 2025.
  • Year by year, Revenue stood at $19.1 million in 2022, then soared by 299.44% to $76.3 million in 2023, then crashed by 35.82% to $48.9 million in 2024, then surged by 93.53% to $94.7 million in 2025, then crashed by 38.98% to $57.8 million in 2026.
  • Business Quant data shows Revenue for STAA at $57.8 million in Q1 2026, $94.7 million in Q3 2025, and $44.3 million in Q2 2025.